VOYAGER THERAPEUTICS INC
VYGRNASDAQ🏆 #3843 by market capEarnings Nov 8US Equity
$2.64▼ $0.06 (−2.22%)
🌙 After hours$2.65▲ 0.38%Regular close · extended-hours price shownTrack VYGR
Get earnings, price moves & breaking news on Telegram
24h▼ 2.2%
7d▼ 8.2%
14d▼ 13.6%
30d▼ 23.7%
ytd▼ 32.8%
1y▼ 43.6%
🏦Market Cap
$160M
Small Cap
📈Revenue Growth (YoY)
-49.5%
Declining
📊Gross Margin
-104.2%
Thin
💵FCF Margin
-352.4%
Thin
⚖️P/S Ratio
4.6x
Fair
Otter Score
88
Very Good
VOYAGER THERAPEUTICS INC
VYGRAnalyst Ratings
Price
$2.64
Total
21
Raised
1
Lowered
3
Avg PT
$14.40
H / L
$18 / $8
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-08-10 | — | — |
Wedbush | Reiterated | Outperform | 2025-08-07 | $8.00 | +203.00% |
Canaccord Genuity | Reiterated | Buy | 2025-03-13 | — | — |
Wells Fargo | Reiterated | Overweight | 2025-03-12 | $10.00 | +278.80% |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-12 | — | — |
Oppenheimer | Reiterated | Outperform | 2024-05-15 | $18.00 | +581.80% |
Truist Securities | Reiterated | Buy | 2023-05-10 | — | — |
Chardan Capital | Reiterated | Neutral | 2021-11-03 | — | — |
Baird | Upgraded | Neutral → Outperform | 2021-10-07 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2021-04-19 | — | — |
BTIG | Downgraded | Buy → Neutral | 2021-02-03 | — | — |
Raymond James | Downgraded | Strong Buy → Outperform | 2020-11-10 | — | — |
Nomura | Reiterated | Buy | 2020-03-30 | — | — |
Benchmark | Reiterated | Buy | 2020-03-19 | — | — |
H.C. Wainwright | Reiterated | Buy | 2018-06-04 | — | — |
Evercore ISI Group | Downgraded | Outperform → In Line | 2018-03-12 | — | — |
BTIG Research | Reiterated | Buy | 2017-12-20 | — | — |
Stifel Nicolaus | Reiterated | Buy | 2017-10-23 | — | — |
Stifel | Reiterated | Buy | 2017-10-23 | — | — |
Cowen & Co. | Reiterated | Outperform | 2015-12-07 | — | — |
PiperJaffray | Reiterated | Overweight | 2015-12-07 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-08-10
—
—
Wedbush
Reiterated · Outperform · 2025-08-07
$8.00
+203.00%
Canaccord Genuity
Reiterated · Buy · 2025-03-13
—
—
Wells Fargo
Reiterated · Overweight · 2025-03-12
$10.00
+278.80%
Cantor Fitzgerald
Reiterated · Overweight · 2025-03-12
—
—
Oppenheimer
Reiterated · Outperform · 2024-05-15
$18.00
+581.80%
Truist Securities
Reiterated · Buy · 2023-05-10
—
—
Chardan Capital
Reiterated · Neutral · 2021-11-03
—
—
Baird
Upgraded · Neutral → Outperform · 2021-10-07
—
—
Morgan Stanley
Reiterated · Equal Weight · 2021-04-19
—
—
BTIG
Downgraded · Buy → Neutral · 2021-02-03
—
—
Raymond James
Downgraded · Strong Buy → Outperform · 2020-11-10
—
—
Nomura
Reiterated · Buy · 2020-03-30
—
—
Benchmark
Reiterated · Buy · 2020-03-19
—
—
H.C. Wainwright
Reiterated · Buy · 2018-06-04
—
—
Evercore ISI Group
Downgraded · Outperform → In Line · 2018-03-12
—
—
BTIG Research
Reiterated · Buy · 2017-12-20
—
—
Stifel Nicolaus
Reiterated · Buy · 2017-10-23
—
—
Stifel
Reiterated · Buy · 2017-10-23
—
—
Cowen & Co.
Reiterated · Outperform · 2015-12-07
—
—
PiperJaffray
Reiterated · Overweight · 2015-12-07
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space